Social Support Aid for People with Dementia

为痴呆症患者提供社会支持援助

基本信息

  • 批准号:
    8248034
  • 负责人:
  • 金额:
    $ 18.3万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2012
  • 资助国家:
    美国
  • 起止时间:
    2012-03-15 至 2014-02-28
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Alzheimer's disease (AD) is the leading cause of dementia and the early stage of the disease is characterized by forgetfulness and trouble with remembering words and names. AD is the leading cause of dementia and the sixth leading cause of death in the United States. AD is not a normal part of aging, but the risk of developing AD increases with age. It is estimated that in 2009, 5.3 million Americans have AD. As the population ages, the number of people with AD will continue to increase to an estimated 7.7 million in 2030 and 11 to 16 million in 2050. The economic costs of treating and caring for people with AD are substantial. Healthcare and long-term care services cost three times as much for individuals with AD or dementia. There are no treatments available to slow or stop brain cell death from AD. This project will validate a face recognition (FR) aid that supports people in the early stages of Alzheimer's disease (AD) in social situations via human subject testing. Typical users are people with an early stage of AD who desire social interaction with a large number of family members and friends. Such people may have several children, grandchildren, in-laws, and neighbors with whom they interact on a weekly or monthly basis. PUBLIC HEALTH RELEVANCE: AD is a progressive disease that often begins with forgetfulness]. In the early stages of AD people may have trouble remembering recent events or the names of familiar people or things. As the disease progresses to middle stage, memory loss and confusion increase and people may have difficulty even recognizing family members.
描述(申请人提供):阿尔茨海默病(AD)是导致痴呆症的主要原因,该病的早期特征是健忘和记忆单词和名字的困难。在美国,AD是导致痴呆症的首要原因,也是导致死亡的第六大原因。AD不是衰老的正常部分,但随着年龄的增长,患AD的风险会增加。据估计,2009年有530万美国人患有阿尔茨海默病。随着人口老龄化,阿尔茨海默病患者的数量将继续增加,2030年估计为770万人,2050年为1100万至1600万人。治疗和照顾阿尔茨海默病患者的经济成本是巨大的。对于阿尔茨海默病或痴呆症患者来说,医疗保健和长期护理服务的费用是前者的三倍。目前还没有可用的治疗方法来减缓或阻止阿尔茨海默病引起的脑细胞死亡。该项目将通过人类受试者测试来验证一种人脸识别(FR)辅助工具,该辅助工具可以在社交环境中支持阿尔茨海默病(AD)早期患者。典型的用户是患有早期AD的人,他们希望与大量的家人和朋友进行社交互动。这样的人可能有几个孩子、孙子、姻亲和邻居,他们每周或每月都会与他们互动。 与公共卫生相关:AD是一种进行性疾病,通常始于健忘]。在AD的早期阶段,人们可能难以记住最近发生的事件或熟悉的人或事的名字。随着疾病的发展到中期,记忆力丧失和神志不清的情况会增加,人们甚至可能难以识别家人。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

GARY D HAVEY其他文献

GARY D HAVEY的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('GARY D HAVEY', 18)}}的其他基金

Home-Based Placement of Feeding Tubes with a Mobile Assistant for Underserved Population
通过移动助手为服务不足的人群在家中放置饲管
  • 批准号:
    10480639
  • 财政年份:
    2022
  • 资助金额:
    $ 18.3万
  • 项目类别:
A Mobile Informatics Solution to Aid in Memory
帮助记忆的移动信息学解决方案
  • 批准号:
    10259813
  • 财政年份:
    2019
  • 资助金额:
    $ 18.3万
  • 项目类别:
A Mobile Informatics Solution to Aid in Memory
帮助记忆的移动信息学解决方案
  • 批准号:
    10227470
  • 财政年份:
    2019
  • 资助金额:
    $ 18.3万
  • 项目类别:
Automated Social Interactive Interface to Monitor and Update Intervention Plans for People with MCI, Alzheimer's and Other Dementias
自动社交互动界面,用于监测和更新 MCI、阿尔茨海默病和其他痴呆症患者的干预计划
  • 批准号:
    9409961
  • 财政年份:
    2017
  • 资助金额:
    $ 18.3万
  • 项目类别:
Automated Social Interactive Interface to Monitor and Update Intervention Plans for People with MCI, Alzheimer's and Other Dementias
自动社交互动界面,用于监测和更新 MCI、阿尔茨海默病和其他痴呆症患者的干预计划
  • 批准号:
    10002162
  • 财政年份:
    2017
  • 资助金额:
    $ 18.3万
  • 项目类别:
Enhanced Imaging for Visual Prostheses
视觉假肢的增强成像
  • 批准号:
    10707243
  • 财政年份:
    2014
  • 资助金额:
    $ 18.3万
  • 项目类别:
Body Worn EMG Controlling of Assistive Robotic Arm for Stroke Rehabilitation
用于中风康复的辅助机械臂的穿戴式肌电图控制
  • 批准号:
    8589235
  • 财政年份:
    2013
  • 资助金额:
    $ 18.3万
  • 项目类别:
Continuous Glucose Monitoring with Graphene-Based Disposable Wireless Sensors
使用基于石墨烯的一次性无线传感器进行连续血糖监测
  • 批准号:
    8633235
  • 财政年份:
    2013
  • 资助金额:
    $ 18.3万
  • 项目类别:
Gaze Steered Microphone Array for Understanding Speech in Noisy Areas
用于理解噪声区域语音的凝视控制麦克风阵列
  • 批准号:
    8522901
  • 财政年份:
    2013
  • 资助金额:
    $ 18.3万
  • 项目类别:
Tools for Coordination Among Caregivers of Patients with Alzheimer's Disease and Other Dementias
阿尔茨海默病和其他痴呆症患者的护理人员之间的协调工具
  • 批准号:
    9269971
  • 财政年份:
    2012
  • 资助金额:
    $ 18.3万
  • 项目类别:

相似海外基金

Interplay between Aging and Tubulin Posttranslational Modifications
衰老与微管蛋白翻译后修饰之间的相互作用
  • 批准号:
    24K18114
  • 财政年份:
    2024
  • 资助金额:
    $ 18.3万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
The Canadian Brain Health and Cognitive Impairment in Aging Knowledge Mobilization Hub: Sharing Stories of Research
加拿大大脑健康和老龄化认知障碍知识动员中心:分享研究故事
  • 批准号:
    498288
  • 财政年份:
    2024
  • 资助金额:
    $ 18.3万
  • 项目类别:
    Operating Grants
EMNANDI: Advanced Characterisation and Aging of Compostable Bioplastics for Automotive Applications
EMNANDI:汽车应用可堆肥生物塑料的高级表征和老化
  • 批准号:
    10089306
  • 财政年份:
    2024
  • 资助金额:
    $ 18.3万
  • 项目类别:
    Collaborative R&D
関節リウマチ患者のSuccessful Agingに向けたフレイル予防対策の構築
类风湿性关节炎患者成功老龄化的衰弱预防措施的建立
  • 批准号:
    23K20339
  • 财政年份:
    2024
  • 资助金额:
    $ 18.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Baycrest Academy for Research and Education Summer Program in Aging (SPA): Strengthening research competencies, cultivating empathy, building interprofessional networks and skills, and fostering innovation among the next generation of healthcare workers t
Baycrest Academy for Research and Education Summer Program in Aging (SPA):加强研究能力,培养同理心,建立跨专业网络和技能,并促进下一代医疗保健工作者的创新
  • 批准号:
    498310
  • 财政年份:
    2024
  • 资助金额:
    $ 18.3万
  • 项目类别:
    Operating Grants
Life course pathways in healthy aging and wellbeing
健康老龄化和福祉的生命历程路径
  • 批准号:
    2740736
  • 财政年份:
    2024
  • 资助金额:
    $ 18.3万
  • 项目类别:
    Studentship
I-Corps: Aging in Place with Artificial Intelligence-Powered Augmented Reality
I-Corps:利用人工智能驱动的增强现实实现原地老龄化
  • 批准号:
    2406592
  • 财政年份:
    2024
  • 资助金额:
    $ 18.3万
  • 项目类别:
    Standard Grant
NSF PRFB FY 2023: Connecting physiological and cellular aging to individual quality in a long-lived free-living mammal.
NSF PRFB 2023 财年:将生理和细胞衰老与长寿自由生活哺乳动物的个体质量联系起来。
  • 批准号:
    2305890
  • 财政年份:
    2024
  • 资助金额:
    $ 18.3万
  • 项目类别:
    Fellowship Award
虚弱高齢者のSuccessful Agingを支える地域課題分析指標と手法の確立
建立区域问题分析指标和方法,支持体弱老年人成功老龄化
  • 批准号:
    23K20355
  • 财政年份:
    2024
  • 资助金额:
    $ 18.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
「ケア期間」に着目したbiological aging指標の開発
开发聚焦“护理期”的生物衰老指数
  • 批准号:
    23K24782
  • 财政年份:
    2024
  • 资助金额:
    $ 18.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了